Thomas Oakley, BA, MBA
Tom is an accomplished senior executive with over 30 years of domestic and international leadership experience in contract research, industrial products and consumer products businesses, the last 25 years of which have been spent in the contract research industry. ...
David Bleakman, PhD
David is an internationally recognized neuroscientist and expert in drug discovery and development who most recently held the position as Chief Scientific Officer of Redpin Therapeutics, a chemogenetics biotechnology company based in New York City, NY. Previously,...
Mark Varney, Ph.D.
Dr. Varney received his Ph.D. and post-doctoral training in Pharmacology from Oxford University, UK. He is Chief Scientific Officer of PsychoGenics, a preclinical CNS service company engaged in psychiatric drug discovery. Dr. Varney has more than 30 years of...
Recent Comments